Kindeva Drug Delivery Overview

  • Status
  • Private

  • Employees
  • 1,306

Employees

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 4

  • Investments
  • 3

Kindeva Drug Delivery General Information

Description

Operator of contract development and manufacturing organization intended to serve the pharmaceutical and biotechnology sectors. The company specializes in formulation, product development and commercial manufacturing and has specific expertise in developing inhalation, transdermal and microneedle drug delivery technologies, thereby enabling clients to better deliver life-changing therapies to patients for the treatment of respiratory illnesses and cardiovascular conditions.

Contact Information

Website
www.kindevadd.com
Formerly Known As
3M Drug Delivery Systems
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 11200 Hudson Road
  • Woodbury, MN 55129
  • United States
+1 (800)
Primary Industry
BPO/Outsource Services
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 11200 Hudson Road
  • Woodbury, MN 55129
  • United States
+1 (800)

Kindeva Drug Delivery Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kindeva Drug Delivery Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kindeva Drug Delivery‘s full profile, request access.

Request a free trial

Kindeva Drug Delivery Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of contract development and manufacturing organization intended to serve the pharmaceutical and biotechnology s
BPO/Outsource Services
Woodbury, MN
1,306 As of 2025

Clearwater, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kindeva Drug Delivery Competitors (1)

One of Kindeva Drug Delivery’s competitors is Bend Bioscience (Formerly CoreRx), a Private Equity-Backed company based in Clearwater, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bend Bioscience (Formerly CoreRx) Private Equity-Backed Clearwater, FL
You’re viewing 1 of 1 competitors. Get the full list »

Kindeva Drug Delivery Patents

  • 746

    Total Documents Applications and Grants

  • Total Patents Families

  • 471

    Granted

  • 80

    Pending

  • Expiring in next 12 mo

Kindeva Drug Delivery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026178292-A1 Microneedle array patch for expression of therapeutics Pending 19-Feb-2025
WO-2026136361-A2 Metered dose inhalers and suspension compositions including polyethylene glycol Pending 17-Dec-2024
WO-2026136361-A3 Metered dose inhalers and suspension compositions including polyethylene glycol Pending 17-Dec-2024
WO-2026096930-A1 Cavitation induced mixing Pending 31-Oct-2024
WO-2026030450-A1 Multi-chamber sequential injection Pending 30-Jul-2024 A61M5/19
To view Kindeva Drug Delivery’s complete patent history, request access »

Kindeva Drug Delivery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kindeva Drug Delivery Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kindeva Drug Delivery‘s full profile, request access.

Request a free trial

Kindeva Drug Delivery Investments (3)

Kindeva Drug Delivery’s most recent deal was a Buyout/LBO with Summit Biosciences. The deal was made on 18-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Summit Biosciences 18-Jan-2024 Buyout/LBO Other Pharmaceuticals and Biotechnology
iPharma Labs 16-Jun-2022 Buyout/LBO Drug Discovery
Meridian Medical Technologies 30-Nov-2021 Buyout/LBO BPO/Outsource Services
To view Kindeva Drug Delivery’s complete investments history, request access »

Kindeva Drug Delivery FAQs

  • Where is Kindeva Drug Delivery headquartered?

    Kindeva Drug Delivery is headquartered in Woodbury, MN.

  • What is the size of Kindeva Drug Delivery?

    Kindeva Drug Delivery has 1,306 total employees.

  • What industry is Kindeva Drug Delivery in?

    Kindeva Drug Delivery’s primary industry is BPO/Outsource Services.

  • Is Kindeva Drug Delivery a private or public company?

    Kindeva Drug Delivery is a Private company.

  • What is Kindeva Drug Delivery’s current revenue?

    The current revenue for Kindeva Drug Delivery is .

  • How much funding has Kindeva Drug Delivery raised over time?

    Kindeva Drug Delivery has raised $390M.

  • Who are Kindeva Drug Delivery’s investors?

    Government of UK, 3M, Altaris, and Monroe Capital have invested in Kindeva Drug Delivery.

  • Who are Kindeva Drug Delivery’s competitors?

    Bend Bioscience (Formerly CoreRx) is a competitor of Kindeva Drug Delivery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process